Markets:

Overview

News

Currencies

International

Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

28.78 +1.08 (+3.90%)

Streaming Delayed Price Updated: 10:04 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Arcus Biosciences Announces New Employment Inducement Grants

September 09, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

August 24, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

August 24, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Return On Capital Employed Insights ↗

August 12, 2022

Via Benzinga

Recap: Arcus Biosciences Q2 Earnings ↗

August 03, 2022

Arcus Biosciences (NYSE:RCUS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:03 PM. Here's what investors need to know about the announcement.

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

August 09, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer

August 08, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Analyst Ratings for Arcus Biosciences ↗

August 04, 2022

Over the past 3 months, 4 analysts have published their opinion on Arcus Biosciences (NYSE:RCUS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update

August 03, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Arcus Biosciences to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

July 27, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

July 26, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

July 11, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

June 24, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

June 09, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

May 31, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

May 24, 2022

From Arcus Biosciences

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 11, 2022

Via Benzinga

Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others ↗

May 11, 2022

Roche isn't the only company working on an anti-TIGIT molecule.

Via Investor's Business Daily

99 Biggest Movers From Yesterday ↗

May 12, 2022

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.

Via Benzinga

52 Stocks Moving In Wednesday's Mid-Day Session ↗

May 11, 2022

Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 11, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 11, 2022

Good morning and welcome back for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

34 Stocks Moving in Wednesday's Pre-Market Session ↗

May 11, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share.

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

May 10, 2022

From Arcus Biosciences

Via Business Wire

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Arcus Posts Encouraging Data For Domvanalimab-Based Regimes In Lung Cancer Settings ↗

May 10, 2022

Via Benzinga

Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study

May 09, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Earnings Scheduled For May 9, 2022 ↗

May 09, 2022

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

Via Benzinga

Arcus Biosciences's Earnings Outlook ↗

May 06, 2022

Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Arcus...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.